Juan Vera - Mar 24, 2022 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Chief Scientific Officer & COO, Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Stock symbol
MRKR
Transactions as of
Mar 24, 2022
Transactions value $
-$16,224
Form type
4
Date filed
3/28/2022, 09:04 PM
Previous filing
Feb 22, 2022
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRKR Common Stock Award $0 +141K +5.49% $0.00 2.71M Mar 24, 2022 Direct F1
transaction MRKR Common Stock Tax liability -$16.2K -33.5K -1.24% $0.48 2.67M Mar 24, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award.
F2 Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs.